Covid-19 Vaccine: A Mutual Partnership between Morocco and China

Since the establishment of diplomatic relations between China and the Kingdom of Morocco (1958), a strong and rapid strategic development of mutual ties categorized contemporary collaboration.

On August 31th 2020, King Mohammed VI held telephone talks with Xi Jinping, President of the People’s Republic of China, which falls within the framework of the existing friendship between the two countries, which was strengthened through the signing of the Joint Declaration on the Establishment of the People’s Republic of China. A strategic partnership was signed by the King and Chinese President during the royal visit to Beijing in May 2016.

The phone talks between King Mohammed VI and the President of the People’s Republic of China touched on the development of bilateral relations in all fields, especially political dialogue, economic cooperation, and cultural and humanitarian exchanges. King Mohammed VI and President Xi Jinping also discussed the partnership between the two countries in combating “Covid-19”.

According to Moroccan Newsmedia, Minister of Health Khalid Ait Taleb is expressed his satisfaction with the signing up of a cooperation agreement between Morocco and China National Biotec Group Limited (CNBG) on the COVID-19 vaccine trials. This shared Moroccan-Chinese collaboration will allow the Kingdom of Morocco to be among the prior served in terms of the vaccine against the COVID-19 pandemic. Also, he added, under his Majesty, The Kingdom of Morocco would be able to take part in creating vaccines in sense of the exchange of Chinese expertise. Though, to strengthen the Sino-Morocco strategic partnership, to boost both countries’ international solidarity and promote health cooperation.

The issue of discovering an anti-“Covid-19” vaccine still raises several controversies, and altercations especially since the kingdom of Morocco issued its participation in the clinical trials of the Chinese vaccine, but without giving any details about how these trials were conducted, or, knowing its initial outcomes.

Accordingly, despite those who attempt to question it, China’s vaccines constitute a trendy choice because they are affordable and can be distributed in a substantial and more successful capacity. Yet, several states which face similar economic issues, people, and ambiance-based impediments are likely to see China’s vaccines as the obvious choice. That does not mean it will be the sole state they do trade with, as several of the states have more than one trade partner.

Though, Chinese vaccines have a competitive price and making capacity, allowing developing countries like Morocco a way out of the pandemic as fast as possible. Unlike European companies, is not only about business; China has also agreed to give billions of vaccines.

China has timely released the latest vaccines information, China’s vaccines are gaining international steam and a growing number of states are following up to obtain them. Whilst the achievements of Moderna and Pzifer are widely lauded, in the end, these companies only complete a part of the jigsaw in ending the COVID-19 crisis. Not everyone has the privilege or infrastructure to buy them. Therefore, the accomplishment of SinoVac, CanSino, and SinoPharm are set to play a significant role in making a difference for billions of people around the world.

According to Jamal Eddine Bouzidi, a doctor specializing in chest diseases, allergies, and immunology, president of the Moroccan Association for Fighting Tuberculosis and Respiratory Diseases, pointed out: “They say that the Chinese vaccine is purely safe, but to make sure of that.” You must wait for a long time because there are side effects that may appear after a period of up to two years or after months at least. Therefore, we might say that it is 100% safe. “

He added, “All vaccines that are produced around the globe go through many phases in the laboratory, then they are analyzed and checked on mammals and followed by humans. And when tested on humans, they also go through three stages; and during each stage, the number” of people subject to testing, so that the effects are discovered. Side effects of the vaccine and its effectiveness. “

Under such circumstances, The Moroccan minister noted that the vaccine, according to the statements of Chinese officials, is successful at a rate of between 97 and 98 percent, and is given in two doses with a difference of 14 days, and the antibodies are manufactured within a month and can sustain in the blood to defend the body for two years. “The vaccine experiments will originally involve volunteers as of next week,” the official said.

Ait Taleb highlighted that the agreements reached will allow Morocco to have its vaccine as soon as possible with the help of our Chinese health expertise. The signing of the agreements will allow Morocco to launch its first experience of clinical trials.

Meanwhile, Al-Bouzidi considered that what is being said is the “only guess”, indicating that the near-term side effects of this vaccine are high temperature, a little fatigue, slight pain at the injection site, and some tremors. The long-term symptoms are not yet known.

As acknowledged by Chinese officials, “Jun Mao” said the signing of the agreements paves the “excellence of strategic relations between China and Morocco in terms of cooperation against COVID-19, which is entering a new phase.” The Chinese diplomat Mao reaffirmed that Rabat and Beijing’s commitment to deepening their cooperation through the clinical trials. He said he hopes the newly-signed agreement will yield “decent results” as soon as possible for the peoples of the two countries.

In conclusion, China has big expectations for the Kingdom of Morocco as the latter has an extreme pond of resources to spur its anticipated vision and China’s economic growth. As a superpower, China’s motive in partnership with Africa through the creation of more legality and impartial world order places the East Asian giant is a powerful stand to provide more substantial aid to Africa under win-win cooperation.

Jamal Laadam
Jamal Laadam
Dr. Jamal Ait Laadam, Specialist in North African and Western Sahara Issue, at Jilin University School of International and Public Affairs (SIPA).